Novo Nordisk building site hit by fire, Danish TV2 reports
COPENHAGEN (Reuters) - A fire broke out at a Novo Nordisk construction site in the Danish city of Kalundborg on Thursday, TV2 News reported, citing local police. A Novo Nordisk spokesperson confirmed there was a fire but declined to comment further...
May 16, 2024
Biogen, Ionis will discontinue development of their ALS drug
(Reuters) - Biogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their treatment for amyotrophic lateral sclerosis (ALS) based on results from an early-stage study. (Reporting by Christy Santhosh; Editing by Son...
May 16, 2024
Johnson & Johnson to acquire Proteologix for $850 million
(Reuters) - Johnson & Johnson on Thursday said it would acquire privately held Proteologix for $850 million in cash, with potential for an additional milestone payment. (Reporting by Sriparna Roy in Bengaluru; Editing by Anil D'Silva)
May 16, 2024
Lilly's weekly insulin succeeds in late-stage studies
(Reuters) - Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in people with type 2 diabetes. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
May 16, 2024
Thai cannabis groups urge government to rethink plan to re-criminalise marijuana
BANGKOK (Reuters) - Dozens of Thai cannabis advocates urged the government on Thursday to abandon its plans to re-list marijuana as an illegal narcotic, a week after it announced its dramatic policy U-turn just two years after de-criminalising it. ...
May 16, 2024
Roche shares gain on obesity drug results from early-stage trial
(Reuters) - Roche shares gained 4.7% at the market open on Thursday after an early-stage trial showed that the obesity drug candidate by newly acquired Carmot Therapeutics led to significant weight loss. The Swiss drugmaker said the study in the fi...
May 16, 2024
AstraZeneca's investigational COVID drug meets primary goals in late-stage study
(Reuters) - AstraZeneca said on Thursday its investigational drug, sipavibart, met primary goals in preventing COVID-19 in immunocompromised patients in a late-stage trial. (Reporting by Eva Mathews in Bengaluru; Editing by Sherry Jacob-Phillips)
May 16, 2024
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday. (Rep...
May 16, 2024
US FDA approves expanded use of Bristol's cancer cell therapy
(Reuters) -The U.S. health regulator said on Wednesday it has approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer that has returned or has not responded to prior treat...
May 15, 2024
Canada says its commercial milk tests negative for bird flu
WASHINGTON (Reuters) - Canadian government officials said samples of commercially sold milk as of May 14 have shown "no evidence" of H5N1 bird flu after enhanced testing aimed at alleviating Canadians concerns following the virus' detection in some...
May 15, 2024